Additionally, hyperglycemia is associated with decreased nerve fiber diameter, reduced number of large myelinated fibers, and decreased nerve conduction velocity, which are more pronounced in cases of early-onset hyperglycemia (Strand et al., 2024)
A: Yes, Semaglutide (particularly Wegovy) is FDA-approved for weight management in individuals with obesity or who are overweight with at least one weight-related conditioneven if they dont have diabetes
It requires monitoring of estradiol, total and free testosterone, hematocrit, PSA, and metabolic markers
We include vitamin D3, since vitamin D receptors are most concentrated in the highest functioning areas of the brain and it is essential for optimum brain function as we age
However, LC at the doses of 0.3 and 0.6 mg/mL were able to neutralize the anti-proliferative effects on TNF-
Learn more: Wegovy plateau: Why weight loss stalls and what to do next Dose considerations when weight loss stalls Finding the right dose of semaglutide for you can take time